These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1789 related items for PubMed ID: 15983284

  • 21. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P, Sarma DN, Low Dog T, Barrett ML, Chavez ML, Ko R, Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI.
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [Abstract] [Full Text] [Related]

  • 22. Recognizing and reporting adverse drug reactions.
    Lucas LM, Colley CA.
    West J Med; 1992 Feb; 156(2):172-5. PubMed ID: 1536067
    [Abstract] [Full Text] [Related]

  • 23. The role of databases in drug postmarketing surveillance.
    Rodriguez EM, Staffa JA, Graham DJ.
    Pharmacoepidemiol Drug Saf; 2001 Feb; 10(5):407-10. PubMed ID: 11802586
    [Abstract] [Full Text] [Related]

  • 24. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P, Montastruc JL.
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [Abstract] [Full Text] [Related]

  • 25. Prediction of drug-related cardiac adverse effects in humans--A: creation of a database of effects and identification of factors affecting their occurrence.
    Matthews EJ, Frid AA.
    Regul Toxicol Pharmacol; 2010 Apr; 56(3):247-75. PubMed ID: 19932726
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I, Dimitrova Z.
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The safety of niacin in the US Food and Drug Administration adverse event reporting database.
    Alsheikh-Ali AA, Karas RH.
    Am J Cardiol; 2008 Apr 17; 101(8A):9B-13B. PubMed ID: 18375244
    [Abstract] [Full Text] [Related]

  • 30. Assessing the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project--six sites, United States, January 1-June 15, 2004.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Apr 22; 54(15):380-3. PubMed ID: 15843786
    [Abstract] [Full Text] [Related]

  • 31. Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Wysowski DK, Green L.
    Obstet Gynecol; 1995 Apr 22; 85(4):538-42. PubMed ID: 7898829
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R, Frassetto L, Tsourounis C, Segal ES, Kim S.
    Postgrad Med; 2010 Nov 22; 122(6):154-64. PubMed ID: 21084792
    [Abstract] [Full Text] [Related]

  • 36. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.
    Budnitz DS, Pollock DA, Mendelsohn AB, Weidenbach KN, McDonald AK, Annest JL.
    Ann Emerg Med; 2005 Feb 22; 45(2):197-206. PubMed ID: 15671977
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
    Jhung MA, Budnitz DS, Mendelsohn AB, Weidenbach KN, Nelson TD, Pollock DA.
    Med Care; 2007 Oct 22; 45(10 Supl 2):S96-102. PubMed ID: 17909391
    [Abstract] [Full Text] [Related]

  • 40. A pharmaceutical manufacturer's perspective on reporting adverse drug experiences.
    Sullivan JW.
    Am J Hosp Pharm; 1990 Jun 22; 47(6):1342-5. PubMed ID: 2368728
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 90.